HIV-induced kidney cell injury: role of ROS-induced downregulated vitamin D receptor.
Reactive oxygen species (ROS) have been demonstrated to contribute to HIV-induced tubular cell injury. We hypothesized that HIV-induced ROS generation may be causing tubular cell injury through downregulation of vitamin D receptor (VDR) and associated downstream effects. In the present study, HIV not only downregulated tubular cell VDR expression but also inflicted DNA injury. On the other hand, EB-1089, a VDR agonist (VD), inhibited both downregulation of VDR and tubular cell DNA injury in the HIV milieu. H(2)O(2) (an O(-) donor) directly downregulated tubular cell VDR, whereas catalase, a free radical scavenger, inhibited HIV-induced downregulation of tubular cell VDR expression. HIV also stimulated the tubular cell renin-angiotensin system (RAS) through downregulation of VDR. Because losartan (an ANG II blolcker) partially inhibited HIV-induced tubular cell ROS generation while ANG II directly stimulated tubular cell ROS generation, it appears that HIV-induced ROS production was partly contributed by the RAS activation. VD not only inhibited HIV-induced RAS activation but also attenuated tubular cell ROS generation. Tubular cells displayed double jeopardy in the HIV milieu induction of double-strand breaks and attenuated DNA repair; additionally, in the HIV milieu, tubular cells exhibited enhanced expression of phospho-p53 and associated downstream signaling. A VDR agonist and an ANG II blocker not only preserved expression of tubular cell DNA repair proteins but also inhibited induction of double-strand breaks. In in vivo studies, renal cortical sections of Tg26 mice displayed attenuated expression of VDR both in podocytes and tubular cells. In addition, renal cortical sections of Tg26 mice displayed enhanced oxidative stress-induced kidney cell DNA damage. These findings indicated that HIV-induced tubular cell downregulation of VDR contributed to the RAS activation and associated tubular cell DNA damage. However, both VD and RAS blockade provided protection against these effects of HIV.
Immunology Center, Feinstein Institute for Medical Research, Hofstra North Shore LIJ Medical School, Great Neck, New York, USA.
Divya
D
Salhan
Mohammad
M
Husain
Ashaan
A
Subrati
Rohan
R
Goyal
Tejinder
T
Singh
Partab
P
Rai
Ashwani
A
Malhotra
Pravin C
PC
Singhal
D016263:AIDS-Associated Nephropathy / Q000209:etiology* / Q000235:genetics; D000818:Animals; D004249:DNA Damage; D004260:DNA Repair; D005260:Female; D005786:Gene Expression Regulation / Q000502:physiology; D006678:HIV / Q000235:genetics*; D015658:HIV Infections / Q000235:genetics; D007684:Kidney Tubules / Q000503:physiopathology; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D018384:Oxidative Stress / Q000502:physiology; D017382:Reactive Oxygen Species / Q000378:metabolism*; D018167:Receptors, Calcitriol / Q000235:genetics / Q000378:metabolism*; D012084:Renin-Angiotensin System / Q000502:physiology
D017382:Reactive Oxygen Species; D018167:Receptors, Calcitriol